Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis

被引:0
|
作者
Weidong Han
Jiansheng Xie
Ling Li
Zhen Liu
Xun Hu
机构
[1] The Second Affiliated Hospital,Cancer Institute (Key Laboratory of Cancer Prevention & Intervention, National Ministry of Education, Provincial Key Laboratory of Molecular Biology in Medical Sciences)
[2] Zhejiang University School of Medicine,Department of Medical Oncology, Sir Run Run Shaw Hospital
[3] Zhejiang University School of Medicine,undefined
来源
Apoptosis | 2009年 / 14卷
关键词
Necroptosis; Necrostatin-1; Apoptosis; Shikonin;
D O I
暂无
中图分类号
学科分类号
摘要
Degterev et al. previously demonstrated that death receptor mediated apoptosis could be diverted to necroptosis when apoptosis signaling was blocked, suggesting that necroptosis may function as a backup mechanism to insure the elimination of damaged cells under certain conditions when apoptosis was inhibited. Here, we show that shikonin-induced necroptosis can be reverted to apoptosis in the presence of necrostatin-1 (Nec-1), a specific necroptosis inhibitor and that the death mode switch is at least partially due to the conversion from mitochondrial inner membrane permeability to mitochondrial outer membrane permeability, which is associated with Bax translocation. The data combined with the previous reports support a notion that apoptosis and necroptosis may function as reciprocal backup mechanisms of cellular demise. To the best of our knowledge, this is the first study to document a conversion from necroptosis to apoptosis.
引用
收藏
页码:674 / 686
页数:12
相关论文
共 50 条
  • [1] Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis
    Han, Weidong
    Xie, Jiansheng
    Li, Ling
    Liu, Zhen
    Hu, Xun
    APOPTOSIS, 2009, 14 (05) : 674 - 686
  • [2] Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications
    Cao, Liyuan
    Mu, Wei
    PHARMACOLOGICAL RESEARCH, 2021, 163
  • [3] Inhibition of RPE ferroptosis by necroptosis inhibitor Necrostatin-1
    Tong, Yao
    Wu, Yinga
    Ma, Jing
    Wang, Shusheng
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [4] Cyclophilin A contributes to shikonin-induced glioma cell necroptosis and promotion of chromatinolysis
    Wang, Xinyu
    Fan, Liwen
    Wang, Xuanzhong
    Luo, Tianfei
    Liu, Linlin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Cyclophilin A contributes to shikonin-induced glioma cell necroptosis and promotion of chromatinolysis
    Xinyu Wang
    Liwen Fan
    Xuanzhong Wang
    Tianfei Luo
    Linlin Liu
    Scientific Reports, 12
  • [6] Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1
    Polito, Letizia
    Bortolotti, Massimo
    Pedrazzi, Manuela
    Mercatelli, Daniele
    Battelli, Maria Giulia
    Bolognesi, Andrea
    PHYTOMEDICINE, 2016, 23 (01) : 32 - 41
  • [7] An in vitro evaluation of the antioxidant activities of necroptosis and apoptosis inhibitors: the potential of necrostatin-1 and necrostatin-1i to have radical scavenging activities
    Ushijima, Hironori
    Monzaki, Rina
    PHARMACOLOGICAL REPORTS, 2023, 75 (02) : 490 - 497
  • [8] Necrostatin-1 improves the cryopreservation efficiency of murine spermatogonial stem cells via suppression of necroptosis and apoptosis
    Jung, Sang-Eun
    Ahn, Jin Seop
    Kim, Yong-Hee
    Oh, Hui-Jo
    Kim, Bang-Jin
    Ryu, Buom-Yong
    THERIOGENOLOGY, 2020, 158 : 445 - 453
  • [9] Necrostatin-1 ameliorates the pathogenesis of experimental autoimmune encephalomyelitis by suppressing apoptosis and necroptosis of oligodendrocyte precursor cells
    Wang, Ying
    Guo, Li
    Wang, Jueqiong
    Shi, Wei
    Xia, Zhilun
    Li, Bin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 4113 - 4119
  • [10] An in vitro evaluation of the antioxidant activities of necroptosis and apoptosis inhibitors: the potential of necrostatin-1 and necrostatin-1i to have radical scavenging activities
    Hironori Ushijima
    Rina Monzaki
    Pharmacological Reports, 2023, 75 : 490 - 497